Estrogen insensitivity syndrome

From WikiMD's Medical Encyclopedia

Revision as of 14:15, 21 February 2025 by Prab (talk | contribs) (CSV import)

Estrogen Insensitivity Syndrome

Structure of the estrogen receptor alpha (ESR1) protein.

Estrogen Insensitivity Syndrome is a rare genetic condition characterized by the body's inability to respond to estrogen, a key hormone in the development and regulation of the female reproductive system and secondary sexual characteristics. This condition is caused by mutations in the estrogen receptor gene, leading to a non-functional receptor that cannot bind estrogen effectively.

Pathophysiology

The syndrome results from mutations in the ESR1 gene, which encodes the estrogen receptor alpha. This receptor is crucial for mediating the effects of estrogen in various tissues, including the breast, uterus, and bone. In individuals with estrogen insensitivity syndrome, the receptor is unable to bind estrogen, leading to a lack of estrogenic effects in the body.

Clinical Presentation

File:Estrogen insensitivity syndrome in a female.png
Clinical presentation of estrogen insensitivity syndrome in a female.

Individuals with estrogen insensitivity syndrome typically present with symptoms of estrogen deficiency despite normal or elevated levels of circulating estrogen. In females, this may include:

  • Lack of breast development
  • Primary amenorrhea
  • Infertility
  • Osteoporosis

In males, the condition may present with:

  • Lack of pubertal development
  • Gynecomastia
  • Infertility

Diagnosis

Diagnosis of estrogen insensitivity syndrome involves a combination of clinical evaluation, hormonal assays, and genetic testing. Elevated levels of circulating estrogen with a lack of expected physiological response suggest the condition. Genetic testing can confirm mutations in the ESR1 gene.

Management

File:Estrogen insensitivity syndrome with adipomastia in a female.png
Estrogen insensitivity syndrome with adipomastia in a female.

Management of estrogen insensitivity syndrome is primarily supportive and symptomatic. Hormone replacement therapy may be considered, although its effectiveness is limited due to the receptor's insensitivity. Management of osteoporosis and other complications is crucial.

Related Pages


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.